A detailed history of Horan Securities, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Horan Securities, Inc. holds 7,076 shares of BMY stock, worth $412,035. This represents 0.14% of its overall portfolio holdings.

Number of Shares
7,076
Previous 7,456 5.1%
Holding current value
$412,035
Previous $309,000 18.45%
% of portfolio
0.14%
Previous 0.13%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $15,070 - $19,665
-380 Reduced 5.1%
7,076 $366,000
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $84,686 - $111,490
2,104 Added 39.31%
7,456 $309,000
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $12,138 - $13,763
253 Added 4.96%
5,352 $290,000
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $9,405 - $11,222
-194 Reduced 3.67%
5,099 $261,000
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $6,541 - $7,314
-113 Reduced 2.09%
5,293 $307,000
Q2 2023

Jul 27, 2023

BUY
$63.71 - $70.74 $30,963 - $34,379
486 Added 9.88%
5,406 $345,000
Q1 2023

Apr 18, 2023

BUY
$65.71 - $74.53 $4,074 - $4,620
62 Added 1.28%
4,920 $341,000
Q4 2022

Jan 17, 2023

BUY
$68.48 - $81.09 $53,962 - $63,898
788 Added 19.36%
4,858 $0
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $50 - $29,890
-389 Reduced 8.72%
4,070 $289,000
Q2 2022

Jul 19, 2022

BUY
$72.62 - $79.98 $289,608 - $318,960
3,988 Added 846.71%
4,459 $329,000
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $1,608 - $1,875
30 Added 6.8%
471 $29,000
Q2 2021

Aug 05, 2021

BUY
$61.91 - $67.42 $18,696 - $20,360
302 Added 217.27%
441 $29,000
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $7,358 - $8,275
124 Added 826.67%
139 $9,000
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $4,792 - $5,430
-83 Reduced 84.69%
15 $1,000
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $4,766 - $5,282
83 Added 553.33%
98 $6,000
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $822 - $961
15 New
15 $1,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Horan Securities, Inc. Portfolio

Follow Horan Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Securities, Inc. with notifications on news.